RGNX R&D to Revenue
Regenxbio Inc · R&D to Revenue
RGNX R&D to Revenue
Latest reported133.95%period ending
RGNX FY R&D/Revenue (82.98% → 133.95%)
Latest values, visible window
High-resolution chart · PNG
RGNX r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 133.9461% | |
| 250.2424% | |
| 257.3813% | |
| 215.0855% | |
| 38.5751% | |
| 107.587% | |
| 352.4679% | |
| 38.3849% | |
| 550.6014% | |
| 991.1092% | |
| 227.7148% | |
| 81.0621% | |
| 82.9801% |